← TrialMatch
HomeTrials

Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients

Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well

Condition(s)Sedation Complication, Mechanical Ventilation Complication
StatusRecruiting
PhaseNA
Study typeInterventional
SummarySedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs. The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a
Who can participateInclusion Criteria: Age 18-90 years Admission to the ICU for less than 24 hours Expected mechanical ventilation for \>48 hours Ongoing sedation Exclusion Criteria: Mechanical ventilation (MV) for less than 48 hours Patient or next of kin refusal to participate BMI \> 35 Cerebrovascular disease Scheduled surgery Neuromuscular disease Presence of craniofacial trauma that prevents the placement of electrodes
Ages18 Years to 90 Years
SexAll
Lead sponsorUniversità degli Studi di Ferrara
LocationsFerrara, Italy, Italy; Naples, Napoli, Italy
Start date2024-01-01
NCT IDNCT06769308
Official listinghttps://clinicaltrials.gov/study/NCT06769308

🔍 Search all trials →